International Laboratory Services passes audit

Published: 12-Nov-2010
Regulatory

Shardlow site undergoes another successful US FDA audit


ILS is pleased to announce another successful US FDA audit of the pharmaceutical facilities at its Shardlow site.

The company says that completion of this audit demonstrates its continued commitment towards high quality analysis for all its pharmaceutical clients.

  • Companies:
  • ILS International Laboratory Services
See more

You may also like

Regulatory

Pharmaceutical heavy metals detection now requires high technology equipment

Read more
A proposed change in the USP test for heavy metals will involve a considerable investment in equipment, training and technology for many organisations

Trending Articles

  1. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  3. Momentum in the US cannabidiol market gains retailers' attention Walmart and other big-name stores in talks with food and drinks makers in preparation for the day CBD-enriched products are allowed on the shelves
  4. Ametek Mocon achieves accreditation for analytical testing laboratory Ametek Mocon, provider of instruments and services for testing, measuring and analysing a variety of gases, has achieved ISO/IEC 17025 accreditation for its Minneapolis analytical testing laboratory
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Regulatory

Pharmaceutical heavy metals detection now requires high technology equipment

A proposed change in the USP test for heavy metals <231> will involve a considerable investment in equipment, training and technology for many organisations
Regulatory

ILS makes further progress with new facility

All media will now be produced in house, giving greater flexibility to meet the changing requirements of customers
Regulatory

ILS wins award for Outstanding Achievement

At the Medilink East Midlands Business Awards
Regulatory

ILS’ plans to return to full operations after recent fire progress to schedule

Sets up temporary lab space for pharma and food microbiology services destroyed in blaze
Regulatory

Fire damages microbiology department at ILS

Derbyshire Fire & Rescue Service to carry out an investigation to establish the cause
Manufacturing

ILS Pharmaceutical Division increases storage stability

New walk-in cabinet brings combined capacity to more than 40,000 litres
Regulatory

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Subscribe now